Autoroad develops high-precision 77GHz and 79GHz millimeter-wave radar systems for intelligent driving applications, including advanced driver-assistance systems (ADAS) and autonomous vehicles. Their technology enhances vehicle perception and safety by providing accurate distance measurement and object detection, addressing the critical need for reliable sensing in automated driving environments.

Elixiron Immunotherapeutics develops therapeutics for cancer and immunological diseases using phage display and single human B cell cloning to create biologics and small molecule inhibitors. Their focus includes targeting specific pathways such as IFN-γ and CSF1R to address conditions like vitiligo, Alzheimer's disease, and various cancers.

Hello TransTech develops smart-sharing bikes and an integrated energy network for electric vehicles, enhancing user experience through a software-defined hardware approach. The platform addresses the need for convenient, affordable, and eco-friendly transportation options in urban areas of China.

Hesai Technology designs and manufactures high-performance lidar sensors for autonomous vehicles and robotics, providing ultra-high resolution and long-range detection capabilities. Their technology enhances safety and navigation in advanced driver-assistance systems (ADAS) by accurately mapping the environment, addressing the need for reliable perception in self-driving applications.

Idmsensor designs and manufactures compact, low‑power gas and pressure sensors—including MEMS, electrochemical, catalytic combustion, infrared, and flexible thin‑film types—for safety‑critical, smart‑home, automotive, environmental and energy‑storage applications. The company provides ready‑to‑use sensor modules and complete detection systems with built‑in signal conditioning, optional wireless connectivity, and customization of target gases and interfaces, supported by in‑house testing and quality management.

KeChow Pharma, Inc. is a biopharmaceutical company focused on the discovery and development of novel small molecule drugs targeting unmet clinical needs in oncology and free radical-related diseases. Their proprietary drug candidates, including the recently approved MEK inhibitor, aim to provide effective treatment options for patients with advanced NRAS-mutant melanoma who have failed existing therapies.

Linkingmed develops an oncology data platform that utilizes artificial intelligence for automated organ delineation, treatment planning, and quality control in radiation therapy. This technology enhances the efficiency and accuracy of cancer treatment processes, addressing the challenges of manual planning and coordination in oncology departments.

Qichacha provides a data and analytics platform that aggregates information on private and public companies in China through mobile apps, web interfaces, and APIs. This service enables users to conduct risk assessments, verify company credentials, and make informed business decisions based on comprehensive credit and legal data.

云知声提供统一的AIoT平台，整合云端AI服务、高性能计算和可选的私有化部署，支持语音识别、合成、声纹和自然语言处理等标准化API。平台还包括低代码的AI芯片应用、全生命周期知识图谱管理以及智能体编排框架，帮助企业在智能家居、医疗、交通等垂直领域快速嵌入多模态AI能力。